| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | VC2W18DGKR |
| InChI Key | IQFYYKKMVGJFEH-XLPZGREQSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C10H14N2O5 |
| Molecular Weight | 242.23 |
| AlogP | -1.51 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 104.55 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 17.0 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Syndrome | Phase 2 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 50-89-5 |
| ChEBI | 17748 |
| ChEMBL | CHEMBL52609 |
| DrugBank | DB04485 |
| EPA CompTox | DTXSID5023661 |
| FDA SRS | VC2W18DGKR |
| Human Metabolome Database | HMDB00273 |
| Guide to Pharmacology | 4718 |
| KEGG | C00214 |
| PDB | THM |
| PubChem | 5789 |
| SureChEMBL | SCHEMBL2722555 |
| ZINC | ZINC000000025672 |